首页> 外文期刊>Journal of cellular and molecular medicine. >Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
【24h】

Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin

机译:鸡胚绒膜尿囊膜测定中体内多种骨髓瘤内皮细胞的血管生成活性与内源性内皮抑素表达下调有关

获取原文
           

摘要

We have attempted a fine characterization of the angiogenic response induced by multiple myeloma endothelial cells (MMEC) by using the chick embryo chorioallantoic membrane (CAM) assay and by reverse transcriptase-polymerase chain reaction (RT-PCR). Results showed that in the CAM assay MMEC induced an angiogenic response comparable to that of a well-known angiogenic cytokine, namely fibroblast growth factor-2 (FGF-2), while RT-PCR demonstrated that the expression of endostatin mRNA detected in MM treated CAM was significantly lower respect to control CAM. These data suggest that angiogenic switch in MM may involve loss of an endogenous angiogenesis inhibitor, such as endostatin.
机译:我们已尝试通过使用雏鸡胚胎绒膜尿囊膜(CAM)测定和逆转录酶-聚合酶链反应(RT-PCR)对由多发性骨髓瘤内皮细胞(MMEC)诱导的血管生成反应进行精细表征。结果表明,在CAM分析中,MMEC诱导的血管生成反应与众所周知的血管生成细胞因子,即成纤维细胞生长因子2(FGF-2)相当,而RT-PCR证实在MM处理中检测到的内皮抑素mRNA表达相对于对照CAM,CAM明显较低。这些数据表明,MM中的血管生成转换可能涉及内源性血管生成抑制剂例如内皮抑素的损失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号